A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Clinical trial NCT04722523 · RECRUITING

Trial details

NCT number: NCT04722523
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Head Cancer Head Cancer Neck Neck Cancer Head and Neck Squamous Cell Carcinoma HNSCC

Start date: 2021-01-20
Primary completion: 2027-06-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.